NAS10029,465−1.17%S&P7,723−0.27%GOLD$4,035−0.40%BTC$81,733+0.57%VIX16.46−2.66%latest tape · as of 16:04 UTC
The Screen · Real Estate · REIT - Hotel & Motel
Pebblebrook Hotel Trust
PEB · the NYSE · USD · Market cap $2.4B · 52 employees
Pebblebrook Hotel Trust is a publicly traded real estate investment trust and the largest owner of urban and resort lifestyle hotels in the United States.
FAIL · Does not pass the screen
20.39 USD
Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 6 days ago
Screened 2026-10-23 · the tape above runs as of 16:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price20.39 USD at the 23 Oct 2026 close
Ethical screenDoes not pass
OptionsOpen interest leans to puts (put/call 1.00)
Last reviewed23 Oct 2026 (6 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 20.39 against the desk's fair-value range, base estimate 20.00, over the last year.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.00, read 2026-10-28
Ethical does not pass the values gate
Price20.39 USD
Fair value20.00
Ethical score70.0/100
Our investment reviews on this name
2026-10-02Read Accumulation18.23+11.8% to today ✓Markdown gives way to Accumulation first Accumulation read since July
2026-09-09Read Markdown18.28+11.5% to today Markup gives way to Markdown
2026-08-08Read Markup19.01+7.3% to today ✓Accumulation gives way to Markup with results news in the headlines
2026-07-02Read Accumulation18.18+12.2% to today ✓First review on file: Accumulation
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Pebblebrook Hotel Trust holds its Accumulation at $20.39. The statistical read favours the sellers, held for 49 days.
As held on the ledger · 2026-10-23
Phase
Accumulation
Quantitative state
The statistical read favours the sellers, held for 49 days
Price at the screen
$20.39
Valuation
N/A trailing · -78.15 forward price to earnings
Values screen
FAIL· score 70.0
Beta
1.44
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
45.94%
Below 33%
Interest-bearing debt is 45.9% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
4.08%
Below 49%
Money owed to the company is 4.1% of assets, under the 49% limit.
Pass
Revenue purity
0.02%
Below 5%
Only 0.0% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Pebblebrook Hotel Trust's business is in a permissible area, but its interest-bearing debt is about 46% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when PEB's ethical verdict changes
Today PEB does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. The price runs 1.9% above the base estimate.
Third-party analyst targets: 15 covering, consensus Hold. The average target sits −2% from the screen price.
Reading the gap · Our model and the Street both land near the screened price: fairly valued, with no strong edge either way.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Hotels Struggle as Travel Recovery Stalls
Picture a string of stylish city hotels and beach resorts sitting half empty while costs keep climbing. Pebblebrook owns 43 of them across urban and resort spots, yet it is still posting losses and negative returns on equity. Revenue is edging up 8 percent, but that has not translated into profits, leaving the forward earnings multiple deep in negative territory.
We pass because the shares sit 12 percent above our fair value estimate and the business shows no durable edge. Fifteen analysts see it as a hold with a median target matching that lower value, and the negative profit margin of 3 percent underlines how little pricing power these assets currently carry.
Hotel cash flows swing hard with economic cycles and consumer spending, so even an ethical screen pass does not remove the risk of further earnings pressure. The combination of overvaluation and thin margins leaves little room for comfort.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
PEB trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-29Accumulation$20.39-3.4%Entry 16
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it hold, with a mean price target of $15. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Accumulation$21.10+0.0%Entry 15
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it hold, with a mean price target of $15. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Accumulation$21.10+0.0%Entry 14
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it hold, with a mean price target of $15. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Accumulation$21.10+0.0%Entry 13
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 38% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it hold, with a mean price target of $15. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Accumulation$21.10+0.0%Entry 12
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it hold, with a mean price target of $15. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Accumulation$21.10+0.0%Entry 11
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it hold, with a mean price target of $15. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Accumulation$21.10+0.0%Entry 10
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it hold, with a mean price target of $15. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Accumulation$21.10+10.4%Entry 9
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 10.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it hold, with a mean price target of $15. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Accumulation$19.11-0.1%Entry 8
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 34% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it hold, with a mean price target of $15.
2026-10-14Accumulation$19.12+4.9%Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 4.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 29% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 77%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (15 analysts) rates it hold, with a mean price target of $15.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
